We do not give medical information nor personal recommendation of any product, treatment or point of view on these pages. We simply collate information that may be of interest.

Ivermectin: is a broad spectrum anti-parasitic agent, included in WHO essential medicines list for several parasitic diseases. It is used in the treatment of onchocerciasis (river blindness), strongyloidiasis and other diseases caused by soil transmitted helminthiasis. It is also used to treat scabies. In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the discovery of ivermectin (IVM), a multifaceted drug deployed against some of the world’s most devastating tropical diseases. IVM has been safely used in 3.7 billion doses since 1987, well tolerated even at much greater than standard doses [34,35]

COVID-19 treatment studies for Ivermectin – c19early.com – Database of all ivermectin COVID-19 studies. 128 studies, 83 peer reviewed, 65 with results comparing treatment and control groups.

Ivermectin is currently used for about 28% of the world’s population. – click here to see a list of these countries and how they are using it. https://ivmstatus.com

Prevention and Treatment Protocols for COVID-19 – I-Mask+, Math+, I-Recover

World Council For Health – At Home Treatment Guide pdf

FLCCC – Front Line COVID-19 Critical Care Alliance – Ivermectin These pages contain the scientific rationale that justifies the use of ivermectin in COVID-19

FLCCC – The Latest Results of Ivermectin’s Success in Treating Outbreaks of COVID-19 – graphs showing covid cases since the inception of use of ivermectin in Zimbabwe, India, Peru, Argentina, Mexico

Israeli scientist says COVID-19 could be treated for under $1/day

Japan drops vax rollout, goes to Ivermectin, ENDS COVID almost overnight – 27th October, 2021

Japan has demonstrated that ivermectin can be used as a more effective cure and a permanent substitute for the Coronavirus vaccines produced by big pharmaceutical companies. – Video posted 9/11/2021

Covid, Ivermectin and the Crime of the Century – Dr. Pierre Kory, Chief Medical Officer of the FLCCC Alliance, joins Bret Weinstein, host of The DarkHorse Podcast to discuss “Covid, Ivermectin and the Crime of the Century.”  This program, which many quickly called “the best podcast I have ever listened to” lays out the truth about ivermectin and how the suppression of its efficacy against COVID-19 has cost hundreds of thousands of people their lives

Dr Tess Lawrie – Director of the Evidence-based Medicine Consultancy in Bath, England, is a world-class researcher and consultant to the World Health Organisation – Interview on Ivermectin – Oracle Films

Interview with Dr. Pierre Kory on why the MATH+ treatment protocol for COVID-19 saves lives

Ivermectin – Interview between Dr Mercola and Dr Hector Cavello – discussion with a medical expert from Argentina, Dr. Hector Carvallo, whose focus since early 2020 has been the prevention and treatment of COVID-19

The Story Of Ivermectin And COVID-19

Ivermectin Wins in India – News of India’s defeat of the Delta variant should be common knowledge. It is just about as obvious as the nose on one’s face. It is so clear when one looks at the graphs that no one can deny it. Yet, for some reason, we are not allowed to talk about it.

Why is the FDA Attacking a Safe Effective Drug? – By David R. Henderson and Charles L. Hooper July 28, 2021

BIRD Group is a non-profit organisation campaigning for the safe medicine ivermectin to be approved to prevent and cure covid-19 around the world

BIRD Group – Evidence & Protocols – On this page we are listing an ever-growing bank of evidence supporting the use of ivermectin for covid-19.

Ivermectin vs Molnupiravir, a comparison – Australian Phillip Altman BPharm (Hons), MSc, PhD gives his detailed comparison of ivermectin and Molnupiravir which Merck is developing as an oral treatment for covid

Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines – American Journal of Therapeutics – “Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.:

Study : Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19 – Conclusion: We believe that the evidence to date supports the worldwide extension of IVM treatments for COVID-19, complementary to immunizations. The indicated biological mechanism of IVM, competitive binding with SARS-CoV-2 spike protein, is likely non-epitope specific, as reviewed [8], possibly yielding full efficacy against emerging viral mutant strains. IVM has been safely used in 3.7 billion doses since 1987, well tolerated even at much greater than standard doses [34,35] and used without serious AEs in the three high-dose COVID-19 treatment studies noted above [34,36,37]. In the current international emergency of COVID-19, with mutant viral strains, vaccination refusals and potentially waning immunities over months presenting new challenges, IVM can be an effective component of the mix of therapeutics deployed against this pandemic.